... biotech corridor, which aims to create 2,000 jobs through 6 million ... SAN ANTONIO SAN DIEGO SEATTLE TAMPA WASHINGTON, D.C.. © 2024 SFist LLC ...
News
- Grand-Scale Mixed-Use Complex Proposed in North Phoenix by Dallas-Based JLB Partners
- BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
("BioAge"), a clinical-stage biotechnology ... The data will be presented at ObesityWeek 2024, held in San Antonio from November 2–6, 2024.
- BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast ...
BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13. November 4, 2024 7:51 ...
- Viking Touts Promising Phase I Weight Loss Data for Obesity Pill Candidate - BioSpace
... San Antonio, Texas. In an investor note, Jefferies analyst Roger Song said that Viking's readout “exceeds expectations” with VK2735 achieving ...
- AstraZeneca still 'playing to win' in obesity, say execs - Fierce Biotech
The hype at the ObesityWeek conference in San Antonio, Texas, may be focused on phase 1 data for Viking Therapeutics' oral GLP-1/GIP dual agonist ...